Status: retired, Primitive. Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
2150923018 | Buprenorphine hydrochloride 8mg + naloxone hydrochloride 2mg sublingual tablet (product) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
2158716014 | Buprenorphine hydrochloride 8mg + naloxone hydrochloride 2mg sublingual tablet | en | Synonym | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Buprenorphine hydrochloride 8mg + naloxone hydrochloride 2mg sublingual tablet | Is a | Buprenorphine hydrochloride + naloxone hydrochloride | false | Inferred relationship | Some | ||
Buprenorphine hydrochloride 8mg + naloxone hydrochloride 2mg sublingual tablet | Has active ingredient | Opiate agonist-antagonist | false | Inferred relationship | Some | ||
Buprenorphine hydrochloride 8mg + naloxone hydrochloride 2mg sublingual tablet | Has active ingredient | Buprenorphine | false | Inferred relationship | Some | ||
Buprenorphine hydrochloride 8mg + naloxone hydrochloride 2mg sublingual tablet | Has active ingredient | Buprenorphine hydrochloride | false | Inferred relationship | Some | ||
Buprenorphine hydrochloride 8mg + naloxone hydrochloride 2mg sublingual tablet | Has active ingredient | Chelating agent | false | Inferred relationship | Some | ||
Buprenorphine hydrochloride 8mg + naloxone hydrochloride 2mg sublingual tablet | Has active ingredient | Central nervous system agent | false | Inferred relationship | Some | ||
Buprenorphine hydrochloride 8mg + naloxone hydrochloride 2mg sublingual tablet | Has active ingredient | Opioid receptor partial agonist | false | Inferred relationship | Some | ||
Buprenorphine hydrochloride 8mg + naloxone hydrochloride 2mg sublingual tablet | Has active ingredient | Naloxone hydrochloride | false | Inferred relationship | Some | ||
Buprenorphine hydrochloride 8mg + naloxone hydrochloride 2mg sublingual tablet | Is a | Buprenorphine- and naloxone-containing product | false | Inferred relationship | Some | ||
Buprenorphine hydrochloride 8mg + naloxone hydrochloride 2mg sublingual tablet | Has manufactured dose form | Oromucosal AND/OR gingival dosage form | false | Inferred relationship | Some | ||
Buprenorphine hydrochloride 8mg + naloxone hydrochloride 2mg sublingual tablet | Has manufactured dose form | Sublingual tablet | false | Inferred relationship | Some | ||
Buprenorphine hydrochloride 8mg + naloxone hydrochloride 2mg sublingual tablet | Is a | Naloxone-containing product in oropharyngeal dose form | false | Inferred relationship | Some | ||
Buprenorphine hydrochloride 8mg + naloxone hydrochloride 2mg sublingual tablet | Is a | Buprenorphine-containing product in oropharyngeal dose form | false | Inferred relationship | Some | ||
Buprenorphine hydrochloride 8mg + naloxone hydrochloride 2mg sublingual tablet | Is a | Buprenorphine- and naloxone-containing product in oropharyngeal dose form | false | Inferred relationship | Some | ||
Buprenorphine hydrochloride 8mg + naloxone hydrochloride 2mg sublingual tablet | Is a | Product manufactured as oromucosal dose form | false | Inferred relationship | Some | ||
Buprenorphine hydrochloride 8mg + naloxone hydrochloride 2mg sublingual tablet | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set